
No noise. No marketing. Practical insight only.
You will also receive The Critical Path — short field notes for leaders committed to maintaining inspection-ready systems every day.
A clear, operator-level summary of Commissioner Makary’s statements —
and what they mean for foreign manufacturers, CDMOs, and API facilities moving forward.
Makary’s remarks were not theoretical.
They reflect a clear shift in regulatory posture.
The FDA is moving from:

For leaders outside the U.S.,
this briefing outlines the practical implications —
and the areas where inspection pressure will increase first.
No noise. No marketing. Practical insight only.


Powered by Severus Engineering - 201 N. Illinois Street, 16th Floor South Tower, Indianapolis, IN, U.S.A.